Dokumente
Suchschritt : FT=glucosamine AND FT=osteoarthritis
» Fenster schließen »

2/3 von 416 DIMDI: MEDLINE (ME60) © NLM

ND: | ME17437663
PMID: | 17437663
CED: | 20070417
Autoren: | Frech TM; Clegg DO
Titel: | The utility of nutraceuticals in the treatment of osteoarthritis.
Quelle: | Current rheumatology reports; VOL: 9 (1); p. 25-30 /200702/
PM: | Print
SU: | IM
Sprache: | English
CY: | United States
JID: | 100888970
ISSN: | 1523-3774
Institution: | Division of Rheumatology, University of Utah School of Medicine, George E. Wahlen Veterans Affairs Medical Center, 4B200 School of Medicine, 50 North Medical Drive, Salt Lake, UT 84132, USA. daniel.clegg@hsc.utah.edu.
DT: | Journal Article
AB: | Osteoarthritis (OA) treatment is limited by the inability of prescribed medications to alter disease outcome. As a result, patients with OA often take food substances called nutraceuticals in an attempt to affect the structural changes that occur within a degenerating joint. The role of nutraceuticals in OA management can be defined only by an evidence-based approach to support their use. This paper reviews the clinical trials studying glucosamine, chondroitin sulfate, vitamin C, vitamin E, and avocado-soybean unsaponifiables. It highlights the need for additional randomized, placebo-controlled trials to further define the utility of nutraceuticals in OA treatment.

» Volltext »
» Fenster schließen »